International platform trials: as diseases cross borders, so should trials
Lancet Infect Dis
.
2023 May;23(5):530-531.
doi: 10.1016/S1473-3099(23)00193-7.
Epub 2023 Mar 23.
Authors
Hiroki Saito
1
;
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) investigators
Affiliation
1
Department of Emergency and Critical Care Medicine, St Marianna University Yokohama Seibu Hospital, Yokohama 241-0811, Japan. Electronic address: hiroki.saito@marianna-u.ac.jp.
PMID:
36966801
PMCID:
PMC10036126
DOI:
10.1016/S1473-3099(23)00193-7
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Adaptive Clinical Trials as Topic
Humans
International Cooperation*